Johan Wedell-Wedellsborg

CIK 1753185 · last filed 2025-09-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

28

Lifetime Open-Market Net

-$21.31M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Y-mAbs Therapeutics, Inc. (YMAB) Delisted Director 4,590,138 $8.61 $39.52M -$21.31M 27 2025-07-02

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-09-03 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Sell (S) −89,166 -$2.37M EDGAR
2019-08-29 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Sell (S) −49,357 -$1.34M EDGAR
2019-08-26 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Sell (S) −990 -$27.5K EDGAR
2019-08-26 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Other (J) −860,105 $0 EDGAR
2019-08-26 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Sell (S) −168,244 -$4.64M EDGAR
2019-08-22 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Sell (S) −168,244 -$4.64M EDGAR
2019-07-17 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Other (J) −860,105 $0 EDGAR
2019-06-14 Y-mAbs Therapeutics, Inc. (YMAB) Delisted Grant (A) $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.